For further details see:
Progenity continues rise following patents on ingestible therapeutics; shares up 32%For further details see:
Progenity continues rise following patents on ingestible therapeutics; shares up 32%Market Wire News is a media platform, the information on this page was provided by SeekingAlpha via Quote Media. Read our full disclaimer.
When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.
Be alerted of any news about your stocks and see what other stocks are trending.
News, Short Squeeze, Breakout and More Instantly...
2024-05-05 06:55:00 ET Don't believe the adage to "sell in May and go away." Buying stocks can still be a smart move, especially if you're a long-term investor. Three Motley Fool contributors have identified stocks they think are no-brainers to buy in May. Here's why they picked Eli L...
2024-05-04 06:45:00 ET Weight loss translates to investor profits. Just look at Eli Lilly and Novo Nordisk . Both stocks have skyrocketed thanks largely to their obesity drugs, with Lilly's share price more than quadrupling and Novo's shares more than tripling over the last three ye...
Pfizer Inc (NYSE:PFE) reported first-quarter earnings Wednesday with adjusted EPS of 82 cents. That’s down 33% year-over-year, beating the ...